Navigation Links
New Analysis of Data Presented at AHA Regarding Effect of Effient® (Prasugrel) on Cardiovascular Events in STEMI Patients According to Timing of PCI
Date:11/16/2011

y of novel oncology and cardiovascular-metabolic therapies. Furthermore, the Daiichi Sankyo Group has created a "Hybrid Business Model," which will respond to market and customer diversity and optimize growth opportunities across the value chain. For more information, please visit www.daiichisankyo.com.

Daiichi Sankyo, Inc., headquartered in Parsippany, New Jersey, is a member of the Daiichi Sankyo Group. For more information on Daiichi Sankyo, Inc., please visit www.dsi.com.

About Eli Lilly and Company

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers – through medicines and information – for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com.  

This press release contains certain forward-looking statements about Effient for the reduction of thrombotic cardiovascular events (including stent thrombosis) in patients with acute coronary syndromes who are managed with percutaneous coronary intervention and reflects Daiichi Sankyo's and Lilly's current beliefs. However, as with any pharmaceutical product, there are substantial risks and uncertainties in the process of development and commercialization. There is no guarantee that future study results and patient experience will be consistent with study findings to date or that the product will be commercially successful. For further discussion of these and other risks and uncertainties, see Lilly's filing with the United States Securities and Exchange Commission and Daiichi Sankyo's filings with the Tokyo Stock Exchange. Daiichi Sankyo and Lilly und
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Triple Analysis: Leukemia, Cancer Vaccines and Peptides
2. Triple Analysis: Prostate Cancer, Angiogenesis and Peptides
3. PRA Early Phase Experts to Speak at Bioanalysis Conference
4. Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
5. New RAPID 1 Post-Hoc Analysis Showed Early Response to Cimzia® (certolizumab pegol) at Week 12 was Predictive of Week 52 Response
6. Turkey Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2017
7. ReportsnReports - Hyper Acute Pancreas (Pancreatic Cancer) - Analysis and Forecasts to 2020
8. Molecular Devices, LLC Introduces SoftMax Pro® 6 Microplate Data Acquisition and Analysis Software With Powerful New Data Analysis and Reporting Features
9. Gastric Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume I 2011
10. DIFICID™ Demonstrated Early Superiority in the First 12 Days Compared to Vancomycin in New Analysis of Phase 3 Study Results
11. Afinitor (Breast Cancer) - Analysis and Forecasts to 2020
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... , July 28, 2015 ... research report with market overview, trends, DRO ... porter analysis, recent developments, competitive scenario and ... Industry Insight: Human Insulin Market Development and ... (Logo: http://photos.prnewswire.com/prnh/20150727/756778) Explore more about ...
(Date:7/28/2015)... and LINCOLNSHIRE, Ill. , ... clinical laboratories to leverage business acumen on par with ... American Association of Clinical Chemistry (AACC) Annual Meeting & ... Beyond a Better Box™ to deliver a comprehensive and ... future unfolds. With advances in four key areas, Sysmex ...
(Date:7/28/2015)... SOUTH SAN FRANCISCO, Calif. , July 28, ... ) today announced that it will report its ... Tuesday, August 4, 2015.  Rigel senior management will ... and webcast at 4:30pm Eastern Time (1:30pm Pacific ... Participants can access the live conference call by ...
Breaking Medicine Technology:Global Human Insulin Market (Size of $24 billion in 2014) to Witness 13% CAGR During 2015 - 2020 2Global Human Insulin Market (Size of $24 billion in 2014) to Witness 13% CAGR During 2015 - 2020 3Global Human Insulin Market (Size of $24 billion in 2014) to Witness 13% CAGR During 2015 - 2020 4Global Human Insulin Market (Size of $24 billion in 2014) to Witness 13% CAGR During 2015 - 2020 5Sysmex Moves Beyond a Better Box 2Sysmex Moves Beyond a Better Box 3Sysmex Moves Beyond a Better Box 4Rigel Announces Conference Call and Webcast to Report Second Quarter 2015 Financial Results 2
... Pfizer said today that,results showing potential across numerous ... cell lung (NSCLC), colorectal,(CRC) and renal cell carcinoma ... will be presented next week at the American ... "Each person with cancer responds differently to treatment, ...
... /PRNewswire/ -- Phase II,results exceed expectations - Alchemia ... development company Alchemia Limited will,commence discussions with the ... conclusion of the Phase II clinical trial,of its ... data from the randomized Phase II clinical trial ...
Cached Medicine Technology:New Pfizer Oncology Data Across Numerous Cancer Types to be,Presented at ASCO 2New Pfizer Oncology Data Across Numerous Cancer Types to be,Presented at ASCO 3New Pfizer Oncology Data Across Numerous Cancer Types to be,Presented at ASCO 4New Pfizer Oncology Data Across Numerous Cancer Types to be,Presented at ASCO 5Positive Final Data from HyCAMP Phase II Trial in Metastatic,Colorectal 2Positive Final Data from HyCAMP Phase II Trial in Metastatic,Colorectal 3Positive Final Data from HyCAMP Phase II Trial in Metastatic,Colorectal 4
(Date:7/28/2015)... ... ... According to WFTV on July 15th heroin overdose rates have ... According to recent statistic Orlando suffers at least one death weekly as a direct ... and law enforcement officials are struggling to keep apace with its distribution. Officers rely ...
(Date:7/28/2015)... (PRWEB) , ... July 28, 2015 , ... ... developing targeted biologics and biologic-device combination products for the treatment of bone disorders ... issued U.S. Patent No. 9,062,300 entitled "Fusion Proteins of Collagen Binding-Domain and Parathyroid ...
(Date:7/28/2015)... ... ... Women fear developing Alzheimer's disease more than having a heart attack or ... treatable, but there is little an individual can do to arrest the progress of ... trial, reports the July 2015 Harvard Women's Health Watch . , "There are ...
(Date:7/28/2015)... ... July 28, 2015 , ... A ... David Wright's Spinal Stenosis Injury" discussed baseball player David Wright’s spinal stenosis injury ... lumbar stenosis, brought on by degenerative changes in the spine, rather than congenital, ...
(Date:7/28/2015)... CO (PRWEB) , ... July 28, 2015 , ... There ... While most people think of highways, bridges and railroads, often overlooked is the over ... of our homes and buildings and into sewage treatment facilities. According to the ...
Breaking Medicine News(10 mins):Health News:Heroin Overdose Deaths Increase by 270 Percent, Orlando Takes the Lead 2Health News:Heroin Overdose Deaths Increase by 270 Percent, Orlando Takes the Lead 3Health News:BiologicsMD, Inc. Announces Additional US Patent Issuance Covering Company’s Pipeline of Targeted Therapies 2Health News:Fight Alzheimer's By Taking Part in a Clinical Trial, From the July 2015 Harvard Women's Health Watch 2Health News:Fight Alzheimer's By Taking Part in a Clinical Trial, From the July 2015 Harvard Women's Health Watch 3Health News:Spine Surgeon Weighs in on Uncertain Future Baseball Career Future for David Wright 2Health News:Spine Surgeon Weighs in on Uncertain Future Baseball Career Future for David Wright 3Health News:With an Infrastructure Spending Bill on the Horizon, RestorationEze Discusses the Impact an Aging Sewer System is Having on Homeowners 2Health News:With an Infrastructure Spending Bill on the Horizon, RestorationEze Discusses the Impact an Aging Sewer System is Having on Homeowners 3
... recent revelation that the chair of the board of ... executive until April 2010 sends an unfortunate message to ... priority, states an editorial http://www.cmaj.ca/cgi/doi/10.1503/cmaj.100850 in CMAJ ... simply no place for the tobacco industry on the ...
... Va., USA Today the International and American Associations for ... (JDR) remains the number one journal of 64 journal ... to the new 2009 Five-Year Scientific Impact Factor (SIF) rankings, ... shows that the JDR,s Five-Year SIF increased from 3.966 to ...
... ... ... As the leading voice for women and men facing infertility, RESOLVE: The National Infertility ... IntegraMed has for RESOLVE’s mission of patient support and education. , , ,“RESOLVE ...
... The most common was mistaking viral for bacterial infections, ... -- You,re not the only one who can,t always ... a bacterial infection that calls for antibiotics: Pediatricians say ... a new study shows. , Other common missed or ...
... The National Heart, Lung, and Blood Institute (NHLBI), part of ... to determine if the safety and efficacy of red blood ... been stored. One of the grants supports the first large, ... patients who receive transfusions of red blood cells that have ...
... ... Life One Year Later. , ... 19, 2010 -- Huntington, New York resident Roger Sencer was driving home from work in May ... seriously wrong, his wife Jane got him to Huntington Hospital. The news was not good: ...
Cached Medicine News:Health News:CMAJ calls for resignation of IDRC chair Barbara McDougall 2Health News:JDR increases its 5-Year SIF and remains number one dental journal of 64 in its category 2Health News:RESOLVE: The National Infertility Association Announces Partnership with Attain Fertility 2Health News:More Than Half of Pediatricians Make Diagnostic Errors: Survey 2Health News:More Than Half of Pediatricians Make Diagnostic Errors: Survey 3Health News:NHLBI funds research to improve safety of red blood cell transfusions 2Health News:NHLBI funds research to improve safety of red blood cell transfusions 3Health News:NHLBI funds research to improve safety of red blood cell transfusions 4Health News:NHLBI funds research to improve safety of red blood cell transfusions 5Health News:NHLBI funds research to improve safety of red blood cell transfusions 6Health News:NHLBI funds research to improve safety of red blood cell transfusions 7Health News:3-D Brain Navigation, Minimally Invasive Surgery Combine to Help Neurosurgeon Remove Tennis Ball-Sized Tumor 2Health News:3-D Brain Navigation, Minimally Invasive Surgery Combine to Help Neurosurgeon Remove Tennis Ball-Sized Tumor 3
The GENESIS II* Total Knee System will define the state of knee implants....
... system's curved-on-curved articulation maintains full inter-changeability. ... options for better patient fit. The ... spray porous coating, which offers an ... processed polyethylene is used for consistent, ...
... new generation of posterior stabilized knee ... the following: Patellar flange mates with ... machined condyles assure precise, repeatable kinematics ... and patella to reduce wear. Constant ...
... The TC-PLUS solution tricompartmental total knee prosthesis ... knee arthroplasty. State-of-the-art design and manufacturing technologies ... optimum biomechanical function as well as a ... tibial insert to keep wear to a ...
Medicine Products: